Cargando…
Management of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief review
BACKGROUND: Recent randomized controlled trial (RCTs) comparing percutaneous closure with antithrombotic treatment in patients with patent foramen ovale (PFO) and cryptogenic stroke revealed inconsistent results. Indeed, there is still no consensus on the management of these patients, namely closure...
Autores principales: | Sidia, Besma, Saleh, Christian, El Issa, Meidi, Mono, Marie-Luise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044138/ https://www.ncbi.nlm.nih.gov/pubmed/30105130 http://dx.doi.org/10.4103/sni.sni_111_18 |
Ejemplares similares
-
Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017) -
Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?
por: Parrini, Iris, et al.
Publicado: (2020) -
Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019) -
Device closure for patent foramen ovale following cryptogenic stroke: a survey of current practice in the UK
por: Von Klemperer, Katherine, et al.
Publicado: (2017) -
Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)